Eyam Vaccines and Immunotherapeutics Secures Global Health Grant to Advance Gemini Expression Platform

September 10, 2024 7:00 AM

VANCOUVER, BC / ACCESSWIRE / September 10, 2024 / Eyam Vaccines and Immunotherapeutics is pleased to announce a new grant from the Bill & Melinda Gates Foundation to support the further development of its Gemini expression platform. The goal of this project is to further develop the platform's potential to deliver durable expression of a protein therapeutic, marking an important step in demonstrating the broader applications of this innovative...

Read more

Global Inhalation Formulation Market Set to Reach USD 60,157.2 million by 2034 | CAGR 3.7% | Future Market Insights, Inc.

September 10, 2024 5:00 AM

The Inhalation Formulation Market is expected to grow steadily over the next decade, reaching an estimated market size of USD 60,157.2 million by 2034, up from USD 41,831.2 million in 2024, with a compound annual growth rate (CAGR) of 3.7% from 2024 to 2034. This growth reflects the rising demand for more efficient and patient-friendly respiratory therapies, particularly for treating chronic respiratory conditions such as asthma, chronic...

Read more

NCQA Announces Keynote Speakers for 2024 Health Innovation Summit

September 9, 2024 5:36 PM

Largest event in quality group's 34-year history will explore quality's futureWASHINGTON, D.C. / ACCESSWIRE / September 9, 2024 / The National Committee for Quality Assurance (NCQA) announced today the keynote speakers for the 2024 Health Innovation Summit, taking place at the Gaylord Opryland Resort & Convention Center, Nashville, TN, October 31 - November 2, 2024. The Summit aims to accelerate quality improvement and connects senior leaders...

Read more

BioNxt Receives Positive International Examination Report From the European Patent Office for Broad Patent Application for Sublingual Delivery of Anticancer Drugs for the Treatment of Autoimmune Neurodegenerative Diseases

September 9, 2024 4:30 PM

VANCOUVER, BC / ACCESSWIRE / September 9, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT) is pleased to report that the European Patent Office ("EPO") has issued a positive international examination report for the Company's comprehensive patent application for sublingual delivery of anticancer drug for the treatment of autoimmune neurodegenerative diseases. The Company expects the EU patent to be...

Read more

Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024

September 9, 2024 4:00 PM

HACKENSACK, NJ / ACCESSWIRE / September 9, 2024 / Champions Oncology, Inc. (CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report its financial and operational results for the first quarter ended July 31, 2024, on Wednesday, September 11, 2024, after market close. The company will host a conference call to discuss the results that day at 4:30 P.M. EDT (1:30 P.M. PDT). To join...

Read more

WiDEF Announces Semifinalists in First Round of Awards

September 9, 2024 3:50 PM

WASHINGTON, DC / ACCESSWIRE / September 9, 2024 / The Women in the Digital Economy Fund (WiDEF) is pleased to announce the semifinalists for its first round of awards. This diverse group of twenty entities represents a range of exceptional work being done in sixteen countries around the world to address gender digital inequities and connect women with technology in meaningful and sustainable ways."These semifinalists represent the future:...

Read more

CELLTech(TM) DBS: Your Brain’s Healing Power Under Your Control

September 9, 2024 2:00 PM

Trisha Pfluger, M.S., PMP, Chief Scientific Officer, and Nicholas Totagrande, CEO, Juno Biomedical, Inc. talk medical advancement, AI, and next steps for CELLTech™ DBS medical technology.ROGERS, AR / ACCESSWIRE / September 9, 2024 / CELLTech™ DBS is the flagship deep brain stimulation (DBS) device of Juno Biomedical, Inc. [Introduction to DBS]. CELLTech™ DBS leverages a unique, proprietary waveform to maximize brain tissue healing after...

Read more

Global Silent Scan Technology Market Poised for Steady Growth, projected to Reach USD 907.9 Million by 2033 at a CAGR of 2.6% | Future Market Insights, Inc.

September 9, 2024 1:30 PM

The global silent scan technology market is set to experience substantial growth, with projections indicating an increase from USD 702.4 million in 2023 to USD 907.9 million by 2033. This impressive expansion represents a compound annual growth rate (CAGR) of 2.6% over the forecast period.Silent scan technology, celebrated for its ability to minimize noise during MRI procedures, is rapidly gaining traction among healthcare providers and patients...

Read more

iCardio.ai and SARC MedIQ PACS Partner to Revolutionize Ultrasound Interpretation With AI Tools

September 9, 2024 12:15 PM

iCardio.ai and SARC MedIQ PACS Partner to Advance AI in HealthcareLOS ANGELES, CA / ACCESSWIRE / September 9, 2024 / Two dynamic startups in the healthcare artificial intelligence sector, iCardio.ai, a Cedars-Sinai backed AI startup, and SARC MedIQ, are thrilled to announce a strategic partnership aimed at revolutionizing the distribution of artificial intelligence tools for clinicians.Sarc and iCardio.ai Partner This partnership marks a...

Read more

Tay-Sachs Awareness Month: Prioritize Your Health With Jscreen

September 9, 2024 11:00 AM

ATLANTA, GA / ACCESSWIRE / September 9, 2024 / Shari Ungerleider and Myra Sack have one thing in common: they both lost a child to Tay-Sachs disease. For Shari, 25 years have passed since she lost her precious son, Evan, while Myra lost her beautiful daughter, Havi, in 2021. It is hard to believe that, after all these years, babies are still born with Tay-Sachs and other devastating genetic diseases. The challenge is ensuring that future...

Read more

Department of Immunology, Institute of Microbiology, Bulgarian Academy of Sciences and Enzolytics, Inc. Execute Three Year Agreement

September 9, 2024 10:00 AM

ALLEN, TX / ACCESSWIRE / September 9, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) ("enzolytics.com") (the "Company") announced today that the Company and the Stephan Angeloff Institute of Microbiology, Department of Immunology, Institute of Microbiology, Bulgarian Academy of Sciences, represented by Professor Tchorbanov PhD, Head of the Department of Immunology and Penka Petrova PHD, DSc, Director of the Institute of Microbiology, entered into a...

Read more

Ankle & Foot Centers of America Gets Athletes Back on the Field

September 9, 2024 9:01 AM

As football season approaches, a national leader in podiatry offers advanced care for sports injuries of the ankle, providing faster recovery and improved performance.PEACHTREE CITY, GA / ACCESSWIRE / September 9, 2024 / As football season begins at the high school and college levels, Ankle & Foot Centers of America, a national leader in podiatry for four decades, announces specialized care that heals the lower-extremity injuries prevalent in...

Read more

Clyra Medical Technologies Appoints Dr. Steven J. Kavros as Chief Medical Officer

September 9, 2024 8:30 AM

Clyra Medical Technologies, Inc., announces the appointment of Dr. Steven J. Kavros as its Chief Medical Officer, with immediate effect.Dr. Kavros brings a wealth of medical expertise and experience in advanced wound healing and limb preservation to his new role at Clyra. He spent over 20 years at the prestigious Mayo Clinic in Rochester, MN, where he served as Director at the Gonda Vascular Wound Healing Center, and was involved in both...

Read more

MilliporeSigma and ABC's Hit Comedy Series "Abbott Elementary" Bring Hands-On STEM to Schools Nationwide

September 9, 2024 8:30 AM

Curiosity Cube mobile science lab offers students and teachers an opportunity to spark curiosity beyond the classroomResearch signals need to bring hands-on science to students to fill future STEM job pipelineBURLINGTON, MA / ACCESSWIRE / September 9, 2024 / MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, is partnering with the Emmy® and Golden Globe®...

Read more

Medholdings Group Inc. Acquires MedSmart Wellness Centers

September 9, 2024 8:30 AM

DENVER, CO / ACCESSWIRE / September 9, 2024 / Med Holdings Group Inc. (OTC PINK:YUKA), a publicly traded company, announced the acquisition of Medsmart Wellness Centers through its subsidiary. This acquisition bolsters Med Holdings Group Inc.'s position, resulting in several data points of growth:Over $2 million in total revenue added to the company's portfolio.$4 million in assets acquired, expanding the company's reach.Strategic move...

Read more

Registration Is Now Open For Tribe Public's Webinar Event "Diabetes, Obesity, GLP-1, & The MODD-1 Opportunity" Featuring Modular Medical CEO On Wednesday, September 11, 2024

September 9, 2024 8:00 AM

Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today announced that Jeb Besser, CEO, will present at Tribe Public's Webinar Presentation and Q&A Event titled "Diabetes, Obesity, GLP-1, & The MODD-1 Opportunity." The event is scheduled to begin at 8:30am pacific/11:30am...

Read more

Quantum Biopharma Signs an Agreement With Ingenu CRO to Conduct a Clinical Study to Observe Disease Progression in Patients With Primary Progressive Multiple Sclerosis

September 9, 2024 7:30 AM

TORONTO, ON / ACCESSWIRE / September 9, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces that through its subsidiary, HUGE Biopharma Australia Pty Ltd., it entered into an agreement with Ingenu CRO Pty Ltd on August 13, 2024 to conduct a clinical study to observe and...

Read more

CureVac to Present First CVGBM Glioblastoma Cancer Vaccine Clinical Data at ESMO 2024 Congress

September 9, 2024 7:15 AM

TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / September 9, 2024 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), today announced that the first clinical data from CureVac's ongoing Phase 1 CVGBM cancer vaccine study in patients with resected glioblastoma will be presented at the European Society for Medical Oncology...

Read more

Moderna’s Canadian Manufacturing Facility Receives Drug Establishment License From Health Canada

September 9, 2024 7:00 AM

Moderna, Inc. (Nasdaq:MRNA) today announced that its manufacturing facility in Laval, Quebec, has been granted a Drug Establishment License (DEL) from Health Canada. This certification affirms the facility's compliance with rigorous safety and quality standards, authorizing it to produce drug substance. This key milestone enables Moderna's Canadian manufacturing site to become fully operational, bringing the company closer to ensuring a reliable...

Read more

Interactive Strength Inc. (Nasdaq: TRNR) to Present at the H.C. Wainwright 26th Annual Global Investment Conference and Meet Institutional Investors in New York from September 9th to 11th

September 9, 2024 7:00 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or "the Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands, today announced that it will be presenting at the H.C. Wainwright 26th Annual Global Investment Conference in New York from September 9th to 11th. In addition, the management team will be available for one-on-one meetings with institutional investors during the conference."Interactive Strength has...

Read more